A multicenter evaluation of the efficacy and duration of action of alcaftadine 0.25% and olopatadine 0.2% in the conjunctival allergen challenge model | Zendy

Stacey Ackerman | Zendy; D'Ambrosio Jr | Zendy; Jack V. Greiner | Zendy; Linda Villanueva | Zendy; Joseph B. Ciolino | Zendy; David Hollander | Zendy

Open Access

A multicenter evaluation of the efficacy and duration of action of alcaftadine 0.25% and olopatadine 0.2% in the conjunctival allergen challenge model

Author(s) -

Stacey Ackerman,

D'Ambrosio Jr,

Jack V. Greiner,

Linda Villanueva,

Joseph B. Ciolino,

David Hollander

Publication year - 2013

Publication title -

journal of asthma and allergy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.162

H-Index - 30

ISSN - 1178-6965

DOI - 10.2147/jaa.s38671

Subject(s) - medicine , allergic conjunctivitis , placebo , itching , onset of action , dermatology , ophthalmology , clinical trial , randomized controlled trial , anesthesia , surgery , allergy , alternative medicine , immunology , pathology

The purpose of this study was to evaluate the efficacy and duration of action of once-daily dosing with alcaftadine 0.25% ophthalmic solution and olopatadine 0.2% ophthalmic solution as compared with placebo in the prevention of ocular itching, and to directly compare the efficacy of alcaftadine 0.25% with olopatadine 0.2% in the prevention of ocular itching associated with allergic conjunctivitis using the conjunctival allergen challenge model.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research